Equibles does not estimate personal net worth.
Get an email with a short summary when Acumen Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get ABOS alertsThe proxy statement of Acumen Pharmaceuticals, Inc. reports total compensation of $637,906 for Eric Siemers in fiscal 2021, including a base salary of $336,159. Disclosed compensation is on record for 2 fiscal years. Eric Siemers has spoken on 3 earnings calls and 2 other investor events across 1 company, most recently for Acumen Pharmaceuticals, Inc. on September 16, 2026. Acumen Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Acumen Pharmaceuticals, Inc. includes Daniel O'Connell (CEO), Dr. George Golumbeski (Chairman and Board Member), Matthew Zuga (CFO) and 2 others.
“I mean, you get a certain amount of variability in these studies just due to patient or study variability from one study to the next. If you look at the mini mental score, that actually is exactly the same in both studies.”
“I mean, you get a certain amount of variability in these studies just due to patient or study variability from one study to the next. If you look at the mini mental score, that actually is exactly the same in both studies.”
“Yeah, and I might just add, we have spent a lot of time thinking about the differentiation of Sobernatog, and I think to sum it, well, obviously, we don't have the data right now.”
“You know, as you mentioned, you know, this is an ongoing blinded study. And so a lot of the answers to the questions you're asking, we'll see at the end of the study.”
“You made an interesting comment about possibly replacing sabernatug with something that's more oligomer-focused. focused uh maybe you can outline your thoughts there because what the shuttles allow you to do is remove plaque safely so the other approach is to use something that's more plaque focused because you know…”
Proxy statement
Start not stated–present
Last confirmed April 23, 2026
Biotechnology · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Acumen Pharmaceuticals, Inc. (ABOS) | Chief Medical Officer | $336,159 | $637,906 |
| 2020 | Acumen Pharmaceuticals, Inc. (ABOS) | Chief Medical Officer | $180,000 | $237,600 |
